Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) released its quarterly earnings results on Wednesday, July, 24th. The medical equipment provider reported $1.26 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider had revenue of $600.70 million for the quarter, compared to analysts' expectations of $599.86 million. Align Technology had a return on equity of 29.26% and a net margin of 19.06%. The company's revenue was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Align Technology.

Align Technology will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Align Technology issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.

13 analysts have issued twelve-month price targets for Align Technology's stock. Their predictions range from $200.00 to $420.00. On average, they anticipate Align Technology's share price to reach $272.60 in the next year. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Align Technology.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

News stories about ALGN stock have been trending neutral this week, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Align Technology.

Align Technology saw a decrease in short interest in September. As of September 30th, there was short interest totalling 3,910,000 shares, a decrease of 6.7% from the August 30th total of 4,190,000 shares. Based on an average daily volume of 1,410,000 shares, the short-interest ratio is currently 2.8 days. Currently, 5.4% of the company's shares are sold short. View Align Technology's Current Options Chain.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Align Technology's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.11%), Commerzbank Aktiengesellschaft FI (0.06%), Gateway Investment Advisers LLC (0.04%), Nisa Investment Advisors LLC (0.04%), CIBC Private Wealth Group LLC (0.03%) and McCollum Christoferson Group LLC (0.02%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Meeder Asset Management Inc., Envestnet Asset Management Inc., Nisa Investment Advisors LLC, Pennsylvania Trust Co, Advisor Partners LLC, Wealthfront Advisers LLC and CIBC Private Wealth Group LLC. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was acquired by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Heritage Investors Management Corp, Intellectus Partners LLC, Foundations Investment Advisors LLC, Summit Creek Advisors LLC, Pacer Advisors Inc., SeaCrest Wealth Management LLC and State of Alaska Department of Revenue. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $214.25.

Align Technology has a market capitalization of $17.11 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]